Year-over-year, this metric declined by 100.0%, from $2.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
A growing balance suggests increasing future liabilities or anticipated restructuring costs, while a shrinking balance indicates the utilization or reversal of these reserves.
Represents the cumulative balance of accruals set aside for specific liabilities related to the Prescription Technology...
Comparable to 'accrued liabilities' or 'restructuring reserves' reported by peers in segment financial disclosures.
mck_segment_prescription_technology_solutions_total_reserve_balance| Q1 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $26.00M | $5.00M | $5.00M | $5.00M | $4.00M | $2.00M | $1.00M | $1.00M | $0.00 | $0.00 |
| QoQ Change | — | +766.7% | -80.8% | +0.0% | +0.0% | -20.0% | -50.0% | -50.0% | +0.0% | -100.0% | — |
| YoY Change | — | +766.7% | — | -80.8% | — | — | -60.0% | -80.0% | -80.0% | -100.0% | -100.0% |